ListarArtículos (Medicina) por materia "Immunotherapy"
Mostrando ítems 1-15 de 15
-
Artículo
Addition of Immune Checkpoint Inhibitors to Chemotherapy vs Chemotherapy Alone as First-Line Treatment in Extensive-Stage Small-Cell Lung Carcinoma: A Systematic Review and Meta-Analysis
(SPRINGER, 2022)Introduction The addition of immune checkpoint inhibitors (ICIs) to conventional chemotherapy (CT) as first-line treatment ...
-
Artículo
Adjuvant pembrolizumab versus placebo in resected high risk stage II melanoma: Health-related quality of life from the randomized phase 3 KEYNOTE-716 study
(Elsevier Science Ltd, 2022)Abstract Background: Adjuvant pembrolizumab significantly improved recurrence-free survival (RFS) versus placebo in ...
-
Artículo
Asthma mortality in Spain from 1980 to 2019. Trends and perspectives in new treatment era
(Sociedad Española de Alergología e Inmunología Clínica, 2023)Background: Previous studies suggest that asthma mortality rates in Spain have been decreasing in recent years. However, ...
-
Artículo
Cancer nano-immunotherapy: the novel and promising weapon to fight cancer
(Mdpi Ag, 2024)Cancer is a complex disease that, despite advances in treatment and the greater understanding of the tumor biology until ...
-
Artículo
Defining the Emergence of New Immunotherapy Approaches in Breast Cancer: Role of Myeloid-Derived Suppressor Cells
(Mdpi Ag, 2023)Breast cancer (BC) continues to be the most diagnosed tumor in women and a very heterogeneous disease both inter- and ...
-
Artículo
First-Line Nivolumab Plus Ipilimumab in Advanced NSCLC: 4-Year Outcomes From the Randomized, Open-Label, Phase 3 CheckMate 227 Part 1 Trial
(ELSEVIER SCIENCE INC, 2022)Introduction: In CheckMate 227, nivolumab plus ipilimu mab prolonged overall survival (OS) versus chemotherapy in patients ...
-
Artículo
Leptin, both bad and good actor in cancer
(MDPI, 2021)Leptin is an important regulator of basal metabolism and food intake, with a pivotal role in obesity. Leptin exerts many ...
-
Artículo
New horizons in breast cancer: the promise of immunotherapy
(Springer, 2019)Immunology and immunotherapy of cancer is an expanding feld in oncology, with recent great achievements obtained through ...
-
Artículo
PD-(L)1 Inhibitors as Monotherapy for the First-Line Treatment of Non-Small-Cell Lung Cancer Patients with High PD-L1 Expression: A Network Meta-Analysis
(MDPI, 2021-03-26)Programmed cell death-ligand 1 (PD-L1) has emerged as a potential biomarker for selection of patients more likely to respond ...
-
Artículo
PECATI: A Multicentric, Open-Label, Single-Arm Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab and Lenvatinib in Pretreated B3-Thymoma and Thymic Carcinoma Patients
(Elsevier, 2022)Thymic epithelial tumors are rare neoplastic proliferations of thymic epithelial cells. The aggressiveness of these ...
-
Artículo
Pembrolizumab Plus Gemcitabine in the Subset of Triple-Negative Advanced Breast Cancer Patients in the GEICAM/2015-04 (PANGEA-Breast) Study
(MDPI, 2021-10-29)The PANGEA-Breast trial evaluated a new chemo-immunotherapeutic combination that would synergistically induce long-term ...
-
Artículo
Real-World Analysis of Nivolumab and Atezolizumab Efficacy in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer
(MDPI, 2022)Nivolumab (anti-PD-1 antibody) and atezolizumab (anti-PD-L1 antibody) have shown superior survival outcomes and improved ...
-
Artículo
Selection of Tumor-Specific Cytotoxic T Lymphocytes in Acute Myeloid Leukemia Patients Through the Identification of T-Cells Capable to Establish Stable Interactions With the Leukemic Cells: “Doublet Technology”
(Frontiers Media, S.A., 2018)The relevance of the immune system in cancer has long been studied. Autologous adoptive T cell therapies, based on the use ...
-
Artículo
SEOM clinical guideline for the management of immune-related adverse events in patients treated with immune checkpoint inhibitors (2019)
(Springer, 2020)The use of immune checkpoint inhibitors has emerged as an effective treatment option for patients with several tumor types. ...
-
Artículo
SEOM clinical guideline for the management of malignant melanoma (2017)
(Springer Int Publ Ag, 2018)All melanoma suspected patients must be con firmed histologically and resected. Sentinel node biopsy must be done when ...